The Clinical Proteomic Tumor Analysis Consortium (CPTAC) suggests that the expression of TRAF2 is significantly positive correlated with CD47 protein levels in lung squamous cell carcinoma (LUSC) among 12 types of tumor (Figure1A,B). Here, TRAF2 is linked to neoplasm.